tradingkey.logo

Inmode Ltd

INMD
查看詳細走勢圖
14.620USD
+0.150+1.04%
收盤 12/26, 16:00美東報價延遲15分鐘
924.12M總市值
6.94本益比TTM

Inmode Ltd

14.620
+0.150+1.04%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.04%

5天

+1.81%

1月

+3.98%

6月

+3.91%

今年開始到現在

-12.46%

1年

-14.10%

查看詳細走勢圖

TradingKey Inmode Ltd股票評分

單位: USD 更新時間: 2025-12-26

操作建議

Inmode Ltd當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名78/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價16.80。中期看,股價處於平穩狀態。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Inmode Ltd評分

相關信息

行業排名
78 / 207
全市場排名
208 / 4563
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 8 分析師
持有
評級
16.800
目標均價
+16.99%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Inmode Ltd亮點

亮點風險
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
估值低估
公司最新PE估值6.94,處於3年歷史低位
機構減倉
最新機構持股33.37M股,環比減少50.57%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉1.15K股

Inmode Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Inmode Ltd簡介

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
公司代碼INMD
公司Inmode Ltd
CEOMizrahy (Moshe)
網址https://inmodemd.com/

常見問題

Inmode Ltd(INMD)的當前股價是多少?

Inmode Ltd(INMD)的當前股價是 14.620。

Inmode Ltd 的股票代碼是什麼?

Inmode Ltd的股票代碼是INMD。

Inmode Ltd股票的52週最高點是多少?

Inmode Ltd股票的52週最高點是19.780。

Inmode Ltd股票的52週最低點是多少?

Inmode Ltd股票的52週最低點是13.140。

Inmode Ltd的市值是多少?

Inmode Ltd的市值是924.12M。

Inmode Ltd的淨利潤是多少?

Inmode Ltd的淨利潤為181.28M。

現在Inmode Ltd(INMD)的股票是買入、持有還是賣出?

根據分析師評級,Inmode Ltd(INMD)的總體評級為持有,目標價格為16.800。

Inmode Ltd(INMD)股票的每股收益(EPS TTM)是多少

Inmode Ltd(INMD)股票的每股收益(EPS TTM)是2.108。
KeyAI